Drug Trial Radar · NCT00162461
Evaluation of CYP2C9 Activity
Last checked: Nov 19, 2026Latest source record: Jun 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,200
Planned (sponsor's estimate)
Start
Aug 1998
Primary completion
Dec 2020
Study completion Dec 2020
Sponsor
- Lead sponsor
- Hadassah Medical OrganizationAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- United States - Israel Binational Science Foundation
- First posted
- Sep 13, 2005
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 20 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The use of phenytoin metabolism to produce S-HPPH accounts for more than 85% of its metabolism. This metabolic pathway is mediated by the activity of CYP2C9. The purpose of the present study is: 1. To confirm the use of phenytoin metabolic ratio as a marker of CYP2C9 activity 2. To correlate phenytoin metabolic ratio with CYP2C9 genotype 3. To study the frequency distribution of CYP2C9 activity in-vivo
Conditions
- Healthy
Interventions
Phenytoin single dose (300 mg)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Correlation between phenytoin metabolic ratio and CYP2C9 genotypeTime frame: 24 hours
- Frequency distribution of phenytoin metabolic ratio in the populationTime frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Hadassah Medical Organization
Jerusalem, Israel · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.